Sorry, you need to enable JavaScript to visit this website.
Thursday, April 11, 2019

There are thought to be approximately 300 pharmaceutical contract development and manufacturing organisations (CDMOs) supporting the pharmaceutical industry. Despite increasing merger and acquisition (M&A) activity, the market remains highly fragmented; the top five CDMOs collectively account for just 15% of the market.

Read the full article here.